56 related articles for article (PubMed ID: 10436826)
1. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.
González González D; Gouma DJ; Rauws EA; van Gulik TM; Bosma A; Koedooder C
Ann Oncol; 1999; 10 Suppl 4():215-20. PubMed ID: 10436826
[TBL] [Abstract][Full Text] [Related]
2. Postoperative brachytherapy and electron beam irradiation for keloids: A single institution retrospective analysis.
Duan Q; Liu J; Luo Z; Hu C
Mol Clin Oncol; 2015 May; 3(3):550-554. PubMed ID: 26137265
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy.
Koo TR; Eom KY; Kim IA; Cho JY; Yoon YS; Hwang DW; Han HS; Kim JS
Radiat Oncol J; 2014 Jun; 32(2):63-9. PubMed ID: 25061574
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study on kilovoltage surface brachytherapy in conjunctival cancer: preliminary results.
Sarria GR; Sarria GJ; Rivera PF; Zaharia M; Serpa S; Buitrago M
Ecancermedicalscience; 2018; 12():835. PubMed ID: 29910832
[TBL] [Abstract][Full Text] [Related]
5. A Case of High-Dose-Rate Brachytherapy Under Endoscopic Retrograde Cholangiopancreatography (ERCP) for Intraductal Papillary Neoplasm of the Bile Duct.
Kawaguchi M; Itonaga T; Mikami R; Sukeda A; Tsuchiya T; Sofuni A; Itoi T; Saito K
Cureus; 2024 Apr; 16(4):e58254. PubMed ID: 38745812
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Kim H; Heo MH; Kim JY
BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
[TBL] [Abstract][Full Text] [Related]
7. CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma.
Harada Y; Miyazaki S
Intern Med; 2018 May; 57(10):1411-1414. PubMed ID: 29279492
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy in the treatment of bile duct cancer - a tough challenge.
Skowronek J; Zwierzchowski G
J Contemp Brachytherapy; 2017 Apr; 9(2):187-195. PubMed ID: 28533809
[TBL] [Abstract][Full Text] [Related]
10. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection.
Leng KM; Liu YP; Wang ZD; Zhong XY; Liao GQ; Kang PC; Cui YF; Jiang XM
Onco Targets Ther; 2017; 10():2257-2266. PubMed ID: 28461760
[TBL] [Abstract][Full Text] [Related]
11. Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer.
Skowronek J; Sowier A; Skrzywanek P
J Contemp Brachytherapy; 2009 Jun; 1(2):97-104. PubMed ID: 27795719
[TBL] [Abstract][Full Text] [Related]
12. Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies.
Cidon EU
Clin Med Insights Oncol; 2016; 10():43-8. PubMed ID: 27199577
[TBL] [Abstract][Full Text] [Related]
13. Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma.
Yeh CN; Hsieh FJ; Chiang KC; Chen JS; Yeh TS; Jan YY; Chen MF
Drug Des Devel Ther; 2015; 9():163-74. PubMed ID: 25552905
[TBL] [Abstract][Full Text] [Related]
14. Update on the management of cholangiocarcinoma.
Skipworth JR; Keane MG; Pereira SP
Dig Dis; 2014; 32(5):570-8. PubMed ID: 25034290
[TBL] [Abstract][Full Text] [Related]
15. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
Skipworth JR; Olde Damink SW; Imber C; Bridgewater J; Pereira SP; Malagó M
Aliment Pharmacol Ther; 2011 Nov; 34(9):1063-78. PubMed ID: 21933219
[TBL] [Abstract][Full Text] [Related]
16. Surgical strategy for bile duct cancer: Advances and current limitations.
Akamatsu N; Sugawara Y; Hashimoto D
World J Clin Oncol; 2011 Feb; 2(2):94-107. PubMed ID: 21603318
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from combined chemoradiotherapy in unresectable and locally advanced resected cholangiocarcinoma.
Leong E; Chen WW; Ng E; Van Hazel G; Mitchell A; Spry N
J Gastrointest Cancer; 2012 Mar; 43(1):50-5. PubMed ID: 21049308
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.
Ghafoori AP; Nelson JW; Willett CG; Chino J; Tyler DS; Hurwitz HI; Uronis HE; Morse MA; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):654-9. PubMed ID: 20864265
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.
Lim KH; Oh DY; Chie EK; Jang JY; Im SA; Kim TY; Kim SW; Ha SW; Bang YJ
BMC Cancer; 2009 Sep; 9():345. PubMed ID: 19781103
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas.
Saito H; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Furuse J; Tsuyuguchi T; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):63-8. PubMed ID: 18274845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
